This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Grocery Sales Poised to Grow as Inflation Cools: 4 Winners
by Ritujay Ghosh
Grocery sales are steadily rising and projected to grow in the near term, helping stocks like Ingredion Incorporated (INGR), McCormick & Company, Incorporated (MKC), TreeHouse Foods, Inc. (THS) and SunOpta Inc. (STKL).
SunOpta (STKL) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
SunOpta (STKL) closed at $5.90 in the latest trading session, marking a -0.34% move from the prior day.
Down -15.31% in 4 Weeks, Here's Why You Should You Buy the Dip in SunOpta (STKL)
by Zacks Equity Research
SunOpta (STKL) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
SunOpta (STKL) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, SunOpta (STKL) closed at $6.34, marking a -0.16% move from the previous day.
Here's Why SunOpta (STKL) is Poised for a Turnaround After Losing -11.15% in 4 Weeks
by Zacks Equity Research
The heavy selling pressure might have exhausted for SunOpta (STKL) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
SunOpta (STKL) and Celsius (CELH) are Aggressive Growth Stocks
by Brian Bolan
Two more stocks for your aggressive growth radar screen
Darling Ingredients (DAR) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Darling (DAR) delivered earnings and revenue surprises of 16% and 8.88%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Vital Farms (VITL) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 300% and 17.40%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
SunOpta (STKL) Q3 Earnings Match Estimates
by Zacks Equity Research
SunOpta (STKL) delivered earnings and revenue surprises of 0% and 2.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Is MGP Ingredients (MGPI) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how MGP (MGPI) and SunOpta (STKL) have performed compared to their sector so far this year.
What Makes SunOpta (STKL) a Good Fit for "Trend Investing"
by Zacks Equity Research
SunOpta (STKL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Wall Street Analysts Believe SunOpta (STKL) Could Rally 41%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for SunOpta (STKL) points to a 41% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Find Highly-Ranked Cheap Stocks Under $10 to Buy with this Screen
by Benjamin Rains
We used one of our Zacks screens to help show investors how to find strong, highly-ranked stocks that are trading for under $10 per share to consider buying as we start to close out August.
Here's Why SunOpta (STKL) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does SunOpta (STKL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Analysts Initiate Coverage: 5 Stocks to Buy for Higher Returns
by Shrabana Mukherjee
Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Professional Holding (PFHD), Trinity (TRIN), SunOpta (STKL), Arcos Dorados (ARCO) and Proto Labs (PRLB).
Will SunOpta (STKL) Gain on Rising Earnings Estimates?
by Zacks Equity Research
SunOpta (STKL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Believe SunOpta (STKL) Could Rally 25%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for SunOpta (STKL) points to a 25% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Recent Price Trend in SunOpta (STKL) is Your Friend, Here's Why
by Zacks Equity Research
SunOpta (STKL) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
SunOpta (STKL) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
SunOpta (STKL) delivered earnings and revenue surprises of 400% and 11.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Sysco (SYY) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Sysco (SYY) delivered earnings and revenue surprises of 31.48% and 5.21%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Mondelez (MDLZ) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Mondelez (MDLZ) delivered earnings and revenue surprises of 13.51% and 3.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Is Medifast (MED) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Medifast (MED) and SunOpta (STKL) have performed compared to their sector so far this year.
Forget Bargains, Play 5 Stocks With Rising P/E Instead
by Sanghamitra Saha
Forget undervalued stocks, there is room for upside even in stocks with rising P/E.
SunOpta (STKL) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
SunOpta (STKL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Momentum Stocks to Buy for December 22nd
by Zacks Equity Research
APTS, NVMI, STKL, and VRS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 22, 2021.